🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Status
Recruiting
Location
Banner University Medical Center - Tucson
Start Date
2023-06-12
Trial ID
NCT05633615
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of lisocab...
Status
Recruiting
Location
University Of Colorado
Start Date
2025-11-06
Trial ID
NCT07015242
This phase II trial studies how well the addition of nemtabrutinib to lisoc...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-09-01
Trial ID
NCT07194980
Treatments Being Tested
This phase II trial tests how well adding lisocabtagene maraleucel (liso-ce...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2023-06-02
Trial ID
NCT05672173
This open-label Phase 1 study will evaluate the safety, PK, and antitumor a...
Status
Completed
Location
Local Institution - 0006
Start Date
2016-01-06
Trial ID
NCT02631044
The goal of the main clinical research study is to learn if treatment with ...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-03-17
Trial ID
NCT07316010
Treatments Being Tested
Diffuse large B-cell lymphoma is the most commonly occurring subtype of non...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2026-03-12
Trial ID
NCT07052305
Treatments Being Tested
This research is being done to assess the effectiveness and safety of acala...
Status
Active Not Recruiting
Location
Massachusetts General Hospital
Start Date
2023-03-01
Trial ID
NCT05583149
Treatments Being Tested